Global CBD Oil Market Size, Share, Trends, and Forecast to 2031

CBD oil is a plant-based extract obtained from cannabis, predominantly sourced from industrial hemp strains that contain very low levels of THC. The extract is commonly blended with carrier oils such as hemp seed oil or coconut oil to enhance bioavailability. Available in various formulations including full-spectrum CBD, which preserves multiple cannabinoids and terpenes, and CBD isolate, offering pure cannabidiol CBD oil has become a widely used ingredient across health, wellness, and personal care industries.

CBD Oil Market

CBD Oil Market Size and Growth

The CBD oil market is set to witness remarkable growth over the coming years, supported by favorable regulatory shifts, expanding product awareness, and rising demand for natural wellness solutions. The market was valued at US$ 5.80 billion in 2024 and is expected to reach US$ 15.66 billion by 2031, growing at an impressive CAGR of 31.2% during the 2025–2031 forecast period.

This growth reflects increasing consumer trust in CBD-based products, particularly as scientific studies continue to explore and validate CBD’s role in managing pain, stress, inflammation, sleep disorders, and certain dermatological conditions. The shift toward preventive healthcare and holistic wellness solutions is further strengthening market adoption worldwide.

Product and Application Landscape

Based on product type, the market is segmented into hemp-derived CBD oil and marijuana-derived CBD oil. Hemp-derived CBD oil holds the largest share due to its widespread legality and acceptance across major markets, especially in North America and Europe. Regulatory frameworks that permit hemp-based CBD products have significantly improved supply chain scalability and retail availability.

From an application standpoint, CBD oil is widely used for pain management, anxiety and depression support, acne treatment, and other therapeutic uses. Pain management remains the most prominent segment, driven by the increasing incidence of chronic pain and consumer preference for alternatives to conventional pharmaceuticals. Applications related to mental well-being are also expanding rapidly, reflecting rising stress levels and growing awareness of CBD’s calming properties.

Distribution Channel Trends

CBD oil products are distributed through online platforms, pharmacies, and food and grocery retail outlets. Online sales channels continue to dominate the market, supported by digital marketing, subscription models, and direct-to-consumer strategies adopted by leading brands. Pharmacies are emerging as a trusted distribution channel as regulatory clarity improves and CBD products gain wider acceptance among healthcare professionals. Meanwhile, food and grocery stores are increasingly stocking CBD products as consumer familiarity grows.

Download PDF Copy- https://www.theinsightpartners.com/sample/TIPRE00021104

Regional Market Insights

North America remains the leading region in the CBD oil market, driven by early legalization, strong consumer demand, and the presence of established manufacturers. Europe follows closely, benefiting from supportive regulatory developments and rising use of CBD in wellness and cosmetic applications. The Asia Pacific region is projected to record the fastest growth rate during the forecast period, fueled by increasing health awareness, rising disposable incomes, and gradual regulatory advancements in countries such as Japan, Australia, and China. Additionally, South and Central America and the Middle East & Africa are emerging as promising markets as governments introduce clearer CBD regulations.

Competitive Landscape and Strategic Focus

The CBD oil market is highly competitive, with companies prioritizing product innovation, research-backed formulations, and strategic partnerships. Market participants are expanding their portfolios to include capsules, edibles, beverages, topical solutions, and beauty products. Investments in clinical research, transparent labeling, and sustainable sourcing are becoming key differentiators. Moreover, collaborations with established wellness brands and expansion into e-commerce are strengthening market reach and consumer engagement.

Leading Companies in the CBD Oil Market

  • Aurora Cannabis Inc.
  • Endoca
  • Medical Marijuana, Inc.
  • NuLeaf Naturals, LLC
  • Elixinol Global Limited
  • CV Sciences, Inc.
  • Canopy Growth
  • Bluebird Botanicals (Gaia Botanicals LLC)
  • Globalcannabinoids.IO
  • Folium Biosciences

Future Market Outlook

The CBD oil market is expected to maintain strong momentum through 2031, supported by increasing legalization, ongoing scientific research, and rising consumer demand for natural health solutions. As regulatory frameworks become more standardized, companies will continue to scale production, improve product quality, and explore new application areas. The integration of CBD oil into mainstream wellness, personal care, and functional food categories is anticipated to unlock further growth opportunities. Market players that focus on innovation, compliance, and consumer education are likely to emerge as long-term leaders in this rapidly evolving industry.

Related Reports-

CBD Hemp Oil Market

Soybean Oil Pharma Grade Market

Comments

Post a Comment

Popular posts from this blog

Global IBS Diagnostics Market Outlook 2026–2034: Forecast to US$ 5.41 Billion

The Irritable Bowel Syndrome diagnostics focus on identifying functional gastrointestinal disorders through symptom assessment, exclusion testing, and advanced laboratory techniques to ensure accurate and timely evaluation. Irritable Bowel Syndrome Diagnostics Market Overview The  Irritable Bowel Syndrome Diagnostics Market  is projected to grow from US$ 3.27 billion in 2025 to US$ 5.41 billion by 2034, registering a CAGR of 5.72% during 2026 to 2034.  This steady expansion reflects the increasing global burden of gastrointestinal disorders and the growing need for accurate, accessible, and patient friendly diagnostic solutions. IBS affects nearly 10 to 16 percent of the global population, making it one of the most common functional gastrointestinal conditions worldwide. IBS diagnostics focus primarily on excluding organic diseases such as celiac disease and inflammatory bowel disease while confirming symptom patterns based on established clinical criteria like Rome IV. ...
Read more

Navigating the Cell‑based Assay Industry: Forecast Period Growth to 2031 Explained

Image
  Cell-based Assay Market Overview and Growth Outlook The Global  Cell-based Assay Market  is projected to reach US$ 36,013 million by 2031, growing at a CAGR of 8.0% from 2025 to 2031.  Cell-based assays have become essential tools in life sciences research, offering high accuracy, reproducibility, and high-throughput capabilities. They are widely used in drug discovery, basic research, and toxicity testing, helping pharmaceutical and biotechnology companies evaluate drug safety and efficacy efficiently. The market is segmented by products and services, applications, and end users. Products and services include consumables, instruments, and specialized services, while applications cover drug discovery, basic research, and other scientific studies. End users comprise pharmaceutical and biotechnology companies, academic and government research institutes, and contract research organizations. Cell-based Assay Market Analysis and Key D...
Read more

Industry Outlook: Malaria Diagnostics Market Growth, Emerging Segments & Technology Trends

Image
  Malaria Diagnostics Market Overview and Growth Trajectory The  malaria diagnostics market  is expected to demonstrate steady expansion as global health systems strengthen disease surveillance and early diagnosis initiatives. The market is projected to grow from  US$ 782.57 million in 2022 to US$ 1,200.24 million by 2030 , registering a  CAGR of 5.5% during 2022–2030 . By 2026, growth momentum is anticipated to be supported by increased investments in malaria elimination programs, improved access to healthcare in endemic regions, and the growing penetration of rapid diagnostic technologies. Malaria continues to pose a significant public health burden, particularly in sub-Saharan Africa and Southeast Asia. Nearly 95% of malaria cases and deaths are reported in the African region, with children under five representing the most vulnerable group. These factors reinforce the need for reliable, fast, and affordable diagnostic solutions across hospitals, clinics, and ...
Read more